- |||||||||| Journal: Prosaposin Is Cleaved Into Saposins by Multiple Cathepsins in a Progranulin-Regulated Fashion. (Pubmed Central) - Jan 23, 2026
We confirmed the role of cathepsins D and B in PSAP processing and identified several additional lysosomal proteases (cathepsins E, K, L, S, V, G, and asparagine-specific endopeptidase) that were able to process PSAP in distinctive, pH-dependent manners. In addition, we found that PGRN and multi-granulin fragments (MGFs) directly regulated the cleavage of PSAP by cathepsin D. With this study, we have shown that multiple cathepsins, PGRN, and MGFs work in concert to produce saposins under different conditions, which could present novel opportunities to modulate saposin levels in disease.
- |||||||||| Journal: Cathepsins in Ischemic Stroke: Unveiling Neuropharmacological Roles and Therapeutic Potential. (Pubmed Central) - Jan 22, 2026
By providing an integrated perspective, this article aims to uncover novel molecular pathways implicated in stroke progression and identify innovative therapeutic strategies centered on cathepsin modulation. Furthermore, this review explores the potential of cathepsins as biomarkers, paving the way for more precise, personalized interventions that could ultimately improve patient outcomes and mitigate long-term disability in ischemic stroke survivors.
- |||||||||| Journal: Probing the activity of cysteine cathepsins in inflammatory bowel diseases. (Pubmed Central) - Jan 21, 2026
Collectively, these results suggest that cathepsin S, but not cathepsin X, may contribute to some of the symptoms of experimental colitis. While cathepsin S has potential to be a therapeutic target in colitis, improved strategies to sustain its inhibition are required in future.
- |||||||||| Review, Journal: The Role of Extracellular Proteases and Extracellular Matrix Remodeling in the Pre-Metastatic Niche. (Pubmed Central) - Dec 30, 2025
These protease-mediated mechanisms represent the earliest interventional window in metastatic progression, offering therapeutic potential to prevent niche formation rather than treat established metastases. However, significant methodological challenges remain, including the need for organ-specific biomarkers, improved in vivo methods for measuring protease activity, and a better understanding of temporal PMN dynamics across different target organs.
- |||||||||| Review, Journal: Targeting Cathepsins in Neurodegeneration: Biochemical Advances. (Pubmed Central) - Dec 30, 2025
Targeting cathepsins presents a promising strategy for treating neurodegenerative and neuropsychiatric disorders, but significant challenges remain. Future research should focus on improving drug specificity and delivery, and on developing standardized models to better predict clinical outcomes.
- |||||||||| Review, Journal: CD74 and Proteases: Impact of Location on Immune and Cellular Functions. (Pubmed Central) - Dec 24, 2025
Proteolytic processing of CD74 can trigger signaling cascades that modulate gene expression, underscoring its multifunctionality. Dysregulation of CD74 cleavage and its interaction with proteases has been linked to diverse pathological conditions, including cancer and autoimmune diseases, where aberrant protease activity disrupts CD74 function and promotes disease progression.
- |||||||||| Journal: Bovine coronavirus enters HRT-18 cells via membrane fusion and clathrin-mediated endocytosis in a low pH-, dynamin-, cholesterol-, microtubule-, Rab7-, and Rab11-dependent manner. (Pubmed Central) - Dec 23, 2025
Here, we reveal that BCoV enters HRT-18 cells via membrane fusion and clathrin-mediated endocytosis, and acidic environment, dynamin, cholesterol, microtubules, cathepsins, Rab7, and Rab11 are also required. This study represents the first report on the mechanism of BCoV cell entry, which advances the understanding of BCoV infection pathogenesis and provides potential targets for the development of novel antiviral drugs.
- |||||||||| Review, Journal: Shaping the Immune Response: Cathepsins in Virus-Dendritic Cell Interactions. (Pubmed Central) - Dec 10, 2025
In this review, we summarize recent advances in understanding the role of cathepsins in DC-virus interactions, emphasizing both how DCs exploit cathepsins to generate protective immune responses and how viruses manipulate cathepsin activity to their advantage. We particularly focus on clinically relevant viral pathogens, including HIV, influenza virus, hepatitis C virus, human cytomegalovirus, Ebola virus, and SARS-CoV-2, to illustrate the multifaceted influence of cathepsins on DC biology during viral infection.
- |||||||||| Journal: A new chemotype that opens the S2? pocket of the 3CL protease exhibits antiviral activity against SARS-CoV-2. (Pubmed Central) - Dec 3, 2025
The binding mode of a closed analog (57) was elucidated by X-ray structure with the protease and revealed the compound opens and fills a new pocket (S2?) untargeted by others inhibitors. This original structural feature along with the promising preliminary results obtained for this new chemotype deserve future optimization to further improve potency and pharmacokinetics properties of this series.
- |||||||||| Review, Journal: It's a Trap!-Potential of Cathepsins in NET Formation. (Pubmed Central) - Nov 27, 2025
These enzymes also influence NET formation, linking classical lysosomal proteolysis to specialized immune responses. This review synthesizes current evidence on cathepsin-mediated regulation of neutrophil effector functions, highlighting their dual role in host defense and disease pathology, and discusses their potential as therapeutic targets for mitigating NET-driven inflammation in conditions such as autoimmune diseases, cancer metastasis, and ischemia-reperfusion injury.
- |||||||||| Preclinical, Journal: CD8+ T Cells Negatively Modulate Ischemia-Induced Angiogenesis in Mice. (Pubmed Central) - Nov 17, 2025
Our findings indicate that CD8a+ T-cell deficiency promotes angiogenesis, and EGCG can reverse the detrimental effects of CD8a+ T-cell activation on angiogenesis. These results provide clinically relevant insights into the potential development of immune-inflammatory therapy targeting vascular diseases.
- |||||||||| Targeting VDAC1 to induce mitochondrial DNA (OCCC - West Halls B3-B4) - Nov 4, 2025 - Abstract #ASH2025ASH_2107;
No abstract available Accordingly, mitochondria are a dynamic hub thatintegrates metabolic stress with innate immune signaling, directly linking to lysosome-dependent cellulardeath by way of the VDAC1
- |||||||||| Review, Journal: Exploring the Role of Exercise and the Lysosomal Cathepsin Family in the Regulation of Vascular-Musculoskeletal Degenerative Diseases. (Pubmed Central) - Oct 11, 2025
The review elucidates several key concepts: the intricate interaction between vascular aging and musculoskeletal degenerative pathologies; the pivotal roles of lysosomal cathepsins in disease progression through metabolic regulation, inflammatory modulation, macrophage polarization, and autophagy dysfunction; and the multifaceted mechanisms by which exercise influences cathepsin activity, including calcium homeostasis, cellular energy metabolism enhancement, inflammatory response reduction, autophagy stimulation, myokine secretion, and vascular function improvement. This comprehensive analysis provides novel insights into exercise as a selective modulator of lysosomal cathepsin activity, highlighting its significant potential for advancing diagnostic and clinical therapeutic approaches.
- |||||||||| Journal: Evolution of the SARS-CoV-2 spike protein in utilizing host transmembrane serine proteases. (Pubmed Central) - Oct 7, 2025
These findings reveal how variant-specific differences in protease usage are linked to spike protein mutations and cleavage site evolution. By illuminating the dynamic interplay between viral adaptation and host protease specificity, this work provides insights into mechanisms that influence viral transmission and immune evasion, with implications for developing targeted antiviral strategies and understanding the evolution of emerging SARS-CoV-2 variants.
- |||||||||| Review, Journal: Host proteases: key regulators in viral infection and therapeutic targeting. (Pubmed Central) - Oct 6, 2025
Elucidating the multidimensional roles of host proteases in infection is crucial for designing the next-generation of broad-spectrum, anti-drug resistance antiviral strategies. This review systematically summarizes the regulatory mechanisms of host proteases at various stages of viral infection and advances in targeted intervention strategies, providing theoretical support for the development of resistance-resistant and broad-spectrum antiviral therapeutics.
- |||||||||| Journal: Proteomic Insight into the Ontogeny of Blood-Meal Digestion in the tick Ixodes ricinus. (Pubmed Central) - Oct 1, 2025
We also detected different types of protease inhibitors and proposed their regulatory role in controlling both endogenous (tick-derived) and host protease activities in the midgut tissue and luminal contents storing ingested blood. These results provide comprehensive insights into the physiology of the tick midgut and offer new opportunities for the development of future control strategies against ticks and tick-borne diseases.
|